United States Irritable Bowel Syndrome (IBS) Market Report 2018

Name: United States Irritable Bowel Syndrome (IBS) Market Report 2018
Brand: QYResearch
SKU: UFBF7F5358BEN
Price: 3800 USD
Availability: InStock

February 2018 | 99 pages | ID: UFBF7F5358BEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Irritable Bowel Syndrome (IBS) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Irritable Bowel Syndrome (IBS) in these regions, from 2013 to 2025 (forecast).

United States Irritable Bowel Syndrome (IBS) market competition by top manufacturers/players, with Irritable Bowel Syndrome (IBS) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

IBS-D Drug
IBS-C Drug
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Women
Men

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Irritable Bowel Syndrome (IBS) Market Report 2018

1 IRRITABLE BOWEL SYNDROME (IBS) OVERVIEW

1.1 Product Overview and Scope of Irritable Bowel Syndrome (IBS)
1.2 Classification of Irritable Bowel Syndrome (IBS) by Product Category
  1.2.1 United States Irritable Bowel Syndrome (IBS) Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Irritable Bowel Syndrome (IBS) Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 IBS-D Drug
  1.2.4 IBS-C Drug
  1.2.5 Other
1.3 United States Irritable Bowel Syndrome (IBS) Market by Application/End Users
  1.3.1 United States Irritable Bowel Syndrome (IBS) Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Women
  1.3.3 Men
1.4 United States Irritable Bowel Syndrome (IBS) Market by Region
  1.4.1 United States Irritable Bowel Syndrome (IBS) Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Irritable Bowel Syndrome (IBS) Status and Prospect (2013-2025)
  1.4.3 Southwest Irritable Bowel Syndrome (IBS) Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Irritable Bowel Syndrome (IBS) Status and Prospect (2013-2025)
  1.4.5 New England Irritable Bowel Syndrome (IBS) Status and Prospect (2013-2025)
  1.4.6 The South Irritable Bowel Syndrome (IBS) Status and Prospect (2013-2025)
  1.4.7 The Midwest Irritable Bowel Syndrome (IBS) Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Irritable Bowel Syndrome (IBS) (2013-2025)
  1.5.1 United States Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2025)
  1.5.2 United States Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2025)

2 UNITED STATES IRRITABLE BOWEL SYNDROME (IBS) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Irritable Bowel Syndrome (IBS) Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Irritable Bowel Syndrome (IBS) Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Irritable Bowel Syndrome (IBS) Average Price by Players/Suppliers (2013-2018)
2.4 United States Irritable Bowel Syndrome (IBS) Market Competitive Situation and Trends
  2.4.1 United States Irritable Bowel Syndrome (IBS) Market Concentration Rate
  2.4.2 United States Irritable Bowel Syndrome (IBS) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES IRRITABLE BOWEL SYNDROME (IBS) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Irritable Bowel Syndrome (IBS) Sales and Market Share by Region (2013-2018)
3.2 United States Irritable Bowel Syndrome (IBS) Revenue and Market Share by Region (2013-2018)
3.3 United States Irritable Bowel Syndrome (IBS) Price by Region (2013-2018)

4 UNITED STATES IRRITABLE BOWEL SYNDROME (IBS) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Irritable Bowel Syndrome (IBS) Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2013-2018)
4.3 United States Irritable Bowel Syndrome (IBS) Price by Type (2013-2018)
4.4 United States Irritable Bowel Syndrome (IBS) Sales Growth Rate by Type (2013-2018)

5 UNITED STATES IRRITABLE BOWEL SYNDROME (IBS) SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Irritable Bowel Syndrome (IBS) Sales and Market Share by Application (2013-2018)
5.2 United States Irritable Bowel Syndrome (IBS) Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES IRRITABLE BOWEL SYNDROME (IBS) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allergan
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Valeant Pharmaceuticals
  6.2.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Takeda
  6.3.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Sucampo Pharmaceuticals
  6.4.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 McNeil Consumer Healthcare
  6.5.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Sebela Pharmaceuticals
  6.6.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Astellas Pharmaceuticals
  6.7.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 IM HealthScience
  6.8.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 IRRITABLE BOWEL SYNDROME (IBS) MANUFACTURING COST ANALYSIS

7.1 Irritable Bowel Syndrome (IBS) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Irritable Bowel Syndrome (IBS) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Irritable Bowel Syndrome (IBS) Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IRRITABLE BOWEL SYNDROME (IBS) MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Irritable Bowel Syndrome (IBS) Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Irritable Bowel Syndrome (IBS) Sales Volume Forecast by Type (2018-2025)
11.3 United States Irritable Bowel Syndrome (IBS) Sales Volume Forecast by Application (2018-2025)
11.4 United States Irritable Bowel Syndrome (IBS) Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Irritable Bowel Syndrome (IBS)
Figure United States Irritable Bowel Syndrome (IBS) Market Size (Kg) by Type (2013-2025)
Figure United States Irritable Bowel Syndrome (IBS) Sales Volume Market Share by Type (Product Category) in 2017
Figure IBS-D Drug Product Picture
Figure IBS-C Drug Product Picture
Figure Other Product Picture
Figure United States Irritable Bowel Syndrome (IBS) Market Size (Kg) by Application (2013-2025)
Figure United States Sales Market Share of Irritable Bowel Syndrome (IBS) by Application in 2017
Figure Women Examples
Table Key Downstream Customer in Women
Figure Men Examples
Table Key Downstream Customer in Men
Figure United States Irritable Bowel Syndrome (IBS) Market Size (Million USD) by Region (2013-2025)
Figure The West Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Irritable Bowel Syndrome (IBS) Sales (Kg) and Growth Rate (2013-2025)
Figure United States Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Irritable Bowel Syndrome (IBS) Market Major Players Product Sales Volume (Kg) (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Sales (Kg) of Key Players/Suppliers (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Irritable Bowel Syndrome (IBS) Sales Share by Players/Suppliers
Figure 2017 United States Irritable Bowel Syndrome (IBS) Sales Share by Players/Suppliers
Figure United States Irritable Bowel Syndrome (IBS) Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Irritable Bowel Syndrome (IBS) Revenue Share by Players/Suppliers
Figure 2017 United States Irritable Bowel Syndrome (IBS) Revenue Share by Players/Suppliers
Table United States Market Irritable Bowel Syndrome (IBS) Average Price (USD/g) of Key Players/Suppliers (2013-2018)
Figure United States Market Irritable Bowel Syndrome (IBS) Average Price (USD/g) of Key Players/Suppliers in 2017
Figure United States Irritable Bowel Syndrome (IBS) Market Share of Top 3 Players/Suppliers
Figure United States Irritable Bowel Syndrome (IBS) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Irritable Bowel Syndrome (IBS) Product Category
Table United States Irritable Bowel Syndrome (IBS) Sales (Kg) by Region (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Sales Share by Region (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Sales Share by Region (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Sales Market Share by Region in 2017
Table United States Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Revenue Share by Region (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Revenue Market Share by Region in 2017
Table United States Irritable Bowel Syndrome (IBS) Price (USD/g) by Region (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Sales (Kg) by Type (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Sales Share by Type (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Sales Share by Type (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2017
Table United States Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Irritable Bowel Syndrome (IBS) by Type (2013-2018)
Figure Revenue Market Share of Irritable Bowel Syndrome (IBS) by Type in 2017
Table United States Irritable Bowel Syndrome (IBS) Price (USD/g) by Types (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Sales Growth Rate by Type (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Sales (Kg) by Application (2013-2018)
Table United States Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2017
Table United States Irritable Bowel Syndrome (IBS) Sales Growth Rate by Application (2013-2018)
Figure United States Irritable Bowel Syndrome (IBS) Sales Growth Rate by Application (2013-2018)
Table Allergan Basic Information List
Table Allergan Irritable Bowel Syndrome (IBS) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
Figure Allergan Irritable Bowel Syndrome (IBS) Sales Growth Rate (2013-2018)
Figure Allergan Irritable Bowel Syndrome (IBS) Sales Market Share in United States (2013-2018)
Figure Allergan Irritable Bowel Syndrome (IBS) Revenue Market Share in United States (2013-2018)
Table Valeant Pharmaceuticals Basic Information List
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
Figure Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Market Share in United States (2013-2018)
Figure Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Market Share in United States (2013-2018)
Table Takeda Basic Information List
Table Takeda Irritable Bowel Syndrome (IBS) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
Figure Takeda Irritable Bowel Syndrome (IBS) Sales Growth Rate (2013-2018)
Figure Takeda Irritable Bowel Syndrome (IBS) Sales Market Share in United States (2013-2018)
Figure Takeda Irritable Bowel Syndrome (IBS) Revenue Market Share in United States (2013-2018)
Table Sucampo Pharmaceuticals Basic Information List
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
Figure Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Growth Rate (2013-2018)
Figure Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Market Share in United States (2013-2018)
Figure Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Market Share in United States (2013-2018)
Table McNeil Consumer Healthcare Basic Information List
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
Figure McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales Growth Rate (2013-2018)
Figure McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales Market Share in United States (2013-2018)
Figure McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue Market Share in United States (2013-2018)
Table Sebela Pharmaceuticals Basic Information List
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
Figure Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Growth Rate (2013-2018)
Figure Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Market Share in United States (2013-2018)
Figure Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Market Share in United States (2013-2018)
Table Astellas Pharmaceuticals Basic Information List
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Growth Rate (2013-2018)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Market Share in United States (2013-2018)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Market Share in United States (2013-2018)
Table IM HealthScience Basic Information List
Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
Figure IM HealthScience Irritable Bowel Syndrome (IBS) Sales Growth Rate (2013-2018)
Figure IM HealthScience Irritable Bowel Syndrome (IBS) Sales Market Share in United States (2013-2018)
Figure IM HealthScience Irritable Bowel Syndrome (IBS) Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Irritable Bowel Syndrome (IBS)
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS)
Figure Irritable Bowel Syndrome (IBS) Industrial Chain Analysis
Table Raw Materials Sources of Irritable Bowel Syndrome (IBS) Major Players/Suppliers in 2017
Table Major Buyers of Irritable Bowel Syndrome (IBS)
Table Distributors/Traders List
Figure United States Irritable Bowel Syndrome (IBS) Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure United States Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Irritable Bowel Syndrome (IBS) Price (USD/g) Trend Forecast (2018-2025)
Table United States Irritable Bowel Syndrome (IBS) Sales Volume (Kg) Forecast by Type (2018-2025)
Figure United States Irritable Bowel Syndrome (IBS) Sales Volume (Kg) Forecast by Type (2018-2025)
Figure United States Irritable Bowel Syndrome (IBS) Sales Volume (Kg) Forecast by Type in 2025
Table United States Irritable Bowel Syndrome (IBS) Sales Volume (Kg) Forecast by Application (2018-2025)
Figure United States Irritable Bowel Syndrome (IBS) Sales Volume (Kg) Forecast by Application (2018-2025)
Figure United States Irritable Bowel Syndrome (IBS) Sales Volume (Kg) Forecast by Application in 2025
Table United States Irritable Bowel Syndrome (IBS) Sales Volume (Kg) Forecast by Region (2018-2025)
Table United States Irritable Bowel Syndrome (IBS) Sales Volume Share Forecast by Region (2018-2025)
Figure United States Irritable Bowel Syndrome (IBS) Sales Volume Share Forecast by Region (2018-2025)
Figure United States Irritable Bowel Syndrome (IBS) Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Irritable Bowel Syndrome (IBS) Market Report 2018

More Publications

Need Help?

Ask a Question

Market Reports